Rol' ursodoksikholevoy kisloty v profilaktike zhelchnokamennoy bolezni pri lechenii akromegalii analogami somatostatina


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article is devoted to the prevention of cholelithiasis in patients with acromegaly receiving long-acting synthetic somatostatin analogues (SAs) as a primary or secondary therapy for a long time. The data on the effectiveness of inclusion of ursodeoxycholic acid in the treatment for the prevention of adverse effects of SAs, that make difficult their further use, are presented.

Full Text

Restricted Access

References

  1. Berg C, Petersenn S, Lahner H, et al. Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. J Clin Endocrinol Metab 2010;95(8):3648-56.
  2. Arosio M, Reimondo G, Malchiodi E, et al. Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol 2012;167(2):189-98.
  3. Dekkers OM, Biermasz NR, Pereira AM, et al. Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab. 2008;93(1):61-7.
  4. Katznelson L, Atkinson JL, Cook DM, et al. Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly. Endocr Pract 2011;17 (Suppl. 4):1-44.
  5. Пронин В., Гитель Е., Васильева И. и др. Прогностические факторы эффективности медикаментозного лечения акромегалии // Врач 2010. № 2. С. 39-43.
  6. Мельниченко Г.А., Пронин В.С., Гитель Е.П. и др. Основные слагаемые успешного лечения акромегалии // Доктор Ру 2011. № 9. С. 4-10.
  7. Paisley AN, Paisley, SV, Rowles ME, et al. Treatment of acromegaly improves quality of life, measured by AcroQol. Clin Endocrinol (Oxf) 2007;67(3):358-62.
  8. Bevan JS. The anti-tumoral effects of somatostatin analog therapy in Acromegaly J Clin Endocrinol Metab 2005;90:1856-63.
  9. Caron P, Beckers A, Cullen DR, et al. Efficacy of the new long-acting formulation of lanreotide (lanreotide autogel) in the management of acromegaly. J Clin Endocrinol Metab 2002;87:99-104.
  10. Casarini AP, Jallad RS, Pinto EM, et al. Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment Pituitary 2009;12(4):297-303.
  11. Пронин В.С., Потешкин Ю.Е. Использование аналогов соматостатина в лечении больных акромегалией: возможности применения препарата Соматулин Аутожель // Фарматека 2010. № 3. С. 64-7.
  12. Jallad RS, Musolino NR, Luiz R, et al. Treatment of Acromegaly With Octreotide-LAR: Extensive Experience in a Brazilian Institution Clin Endocrinol 2005;63(2):168-75.
  13. Dowling RH. Review: pathogenesis of gallstones. Pharmacol Ther 2000;14(Suppl 2): 39-47.
  14. Pereira SP, Hussaini SH, Murphy GM, et al. Octreotide increases the proportions of arachidonic acid-rich phospholipids in gall-bladder bile Pharmacol Ther 2001;15(9):1435-43.
  15. Aditi A, Ajmani A, Smita M, et al. Incidence of gall stone formation in acromegalic patients on octreotide therapy. Indian J Endocrinol Metab. 2012;16(3):406-08.
  16. Avila NA, Shawker TH, Roach P, et al. Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy: incidence and time course. J Clin Ultrasound 1998;26(6):289-94.
  17. Venneman NG, van Erpecum KJ. Gallstone disease: Primary and secondary prevention. Best Pract Res Clin Gastroenterol 2006;20(6):1063 - 73.
  18. Буеверов А.О. Возможности клинического применения урсодезоксихолевой кислоты // Consilium Medicum 2005. Т. 7. № 6. C. 18.
  19. Van Berge-Henegouwen GP, Venneman NG, van Erpecum KJ, et al. Drugs affecting biliary lipid secretion and gallbladder motility: their potential role in gallstone treatment and prevention. Curr Drug Targets Immune Endocr Metabol Disord 2005;5(2):185-91.
  20. Plockinger U. Medical Therapy of Acromegaly. International J Endocrinol 2012:22. Article ID 268957.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies